Stock CDXS CODEXIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Codexis, Inc.

Equities

CDXS

US1920051067

Real-time Estimate Cboe BZX
Other stock markets
 11:22:12 2024-04-19 am EDT 		5-day change 1st Jan Change
2.835 USD +1.25% Intraday chart for Codexis, Inc. -0.35% -6.23%
Apr. 11 Codexis, Inc. Appoints Carole Cobb to Its Strategic Advisory Board CI
Feb. 29 Benchmark Upgrades Codexis to Buy From Hold, Price Target is $9 MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Codexis to Report First Quarter 2024 Financial Results on May 2
AQ
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
AQ
Codexis, Inc. Appoints Carole Cobb to Its Strategic Advisory Board
CI
Benchmark Upgrades Codexis to Buy From Hold, Price Target is $9
MT
Codexis: Q4 Earnings Snapshot
AQ
Transcript : Codexis, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Earnings Flash (CDXS) CODEXIS Reports Q4 Revenue $26.6M, vs. Street Est of $18.9M
MT
Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
AQ
Codexis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Codexis Shares Up 31% on Roche Licensing Agreement
DJ
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche
AQ
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche
CI
Codexis to Participate in TD Cowen 44th Annual Health Care Conference
AQ
Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board
AQ
Codexis, Inc Appoints Masad Damha, PhD and Jim Lalonde, PhD to Strategic Advisory Board
CI
Codexis, Inc. Announces Not to Stand for Reelection of Jennifer Aaker as Board of Director
CI
Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28
AQ
Transcript : Codexis, Inc. - Special Call
Codexis, Inc. Enters into Loan and Security Agreement with Innovatus Life Sciences Lending Fund I, LP
CI
Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CDXS Stock
  4. News Codexis, Inc.